Proteomic Scientists Ask, Where Are Cell Biologists? | GenomeWeb

Poor sample preparation, inexact results, a relative inability to show dynamic processes, and a number of other factors have all contributed to the paucity of mass spec-based proteomics work by cell biologists, according to researchers at McGill University and Göteborg University.

As proteomics lurches out of its infancy as a research field, many say they are seeing more biologists, especially cell biologists, entering the fray. But mass spec proteomics is still dominated by analytical chemists with biologists distinctly in the minority.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.